article thumbnail

BioUtah Announces Headline Speakers for the 2020 Virtual Utah Life Sciences Summit

BioTech 365

Jeffrey Shuren, MD, JD, director of the Center for Devices and Radiological Health (CDHR) at the Food and Drug Administration (FDA), and Dr. Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the … Continue reading →

article thumbnail

Genomics England will move HQ to Canary Wharf’s new biocluster

pharmaphorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. facility dedicated to a combination of wet lab and office space, revealed in March, intended as a focal point for life sciences companies in London.

Genome 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. In early November 2022, two Alzheimer’s drugs were tested head-to-head in a first-ever virtual clinical trial 3. We’ve shown that this type of model can work.

article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

We are taking bold steps into the future of drug development, investing strongly in areas at the forefront of the biomedical and technological revolution. Re-imagining Radiology. In particular, AI bears vast potential for advancing radiology.

article thumbnail

Magnus Medical’s SAINT Neuromodulation System Gets FDA Clearance to Treat MDD

XTalks

This week, Magnus Medical’s SAINT Neuromodulation System received 510(k) clearance from the US Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in adults who did not have satisfactory improvement from past antidepressant medications in their current episode. The SAINT Neuromodulation Trial.

article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. I believe the life sciences industry ecosystem is getting to be more familiar with digital health overall as a concept. About the interviewee.

article thumbnail

World Cancer Day 2024: Trends in Oncology Research and More

XTalks

Overcoming drug resistance: A major challenge in cancer treatment is the development of resistance to chemotherapy drugs. CRISPR/Cas9 offers a pathway to potentially overcome this, by modifying genes that are responsible for drug resistance in cancer cells.

Research 118